|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02211 UNI HEALTH
Nominal 
0.550 -0.010 (-1.786%) | 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 266,824 | -39.517% | 441,153 | 591,339 | 796,976 | 616,693 |
| Cost of Sales | (219,376) | -40.836% | (370,790) | (495,157) | (663,376) | (526,818) |
| Gross Profit | 47,448 | -32.567% | 70,363 | 96,182 | 133,600 | 89,875 |
| 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (10,433) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 339 | 662 | (6,727) | (499) | |
| Profit / (Loss) before Taxation | (5,150) | -12.519% | (5,887) | (22,501) | (44,300) | (125,753) | |
| Taxation | (908) | -49.359% | (1,793) | 1,617 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | (332) | (45) | 69 | 241 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (6,058) | -24.388% | (8,012) | (20,929) | (44,231) | (125,512) | |
| 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,744 | -- | (1,707) | 2,166 | (4,226) | 1,400 |
| Depreciation & Amortisation | 6,733 | -2.051% | 6,874 | 7,107 | 8,907 | 20,474 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/12 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/12 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -6.210 | -37.900% | -10.000 | -31.400 | -79.500 | -310.400 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 3.094 | -- | 4.243 | 4.82105 | 6.464274 | 10.078452 |
| Remarks: | Real time quote last updated: 05/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -6,058 |
| %Change | -24.388% |
| EPS / (LPS) | RMB -0.062 |
| NBV Per Share (¥) | RMB 3.094 |